Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of SHILPA MEDICARE. For more details, see the SHILPA MEDICARE quarterly results and SHILPA MEDICARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.2 |
No. of shares | m | 97.79 |
1 Week | % | -1.6 |
1 Month | % | 20.3 |
1 Year | % | 106.1 |
52 week H/L | Rs | 558.0/228.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SHILPA MEDICARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 547 | 539 | 692 | 671 | 503 | |
Low | Rs | 335 | 191 | 251 | 340 | 222 | |
Sales per share (Unadj.) | Rs | 90.0 | 111.4 | 110.5 | 132.0 | 121.0 | |
Earnings per share (Unadj.) | Rs | 13.4 | 19.0 | 17.9 | 7.0 | -3.6 | |
Diluted earnings per share | Rs | 11.2 | 15.8 | 15.0 | 6.2 | -3.2 | |
Cash flow per share (Unadj.) | Rs | 18.6 | 24.3 | 24.6 | 16.2 | 7.4 | |
Dividends per share (Unadj.) | Rs | 1.00 | 1.10 | 1.10 | 1.10 | 0 | |
Adj. dividends per share | Rs | 0.83 | 0.92 | 0.92 | 0.98 | 0.00 | |
Avg Dividend yield | % | 0.2 | 0.3 | 0.2 | 0.2 | 0 | |
Book value per share (Unadj.) | Rs | 146.9 | 163.1 | 181.4 | 209.9 | 205.4 | |
Adj. book value per share | Rs | 122.5 | 135.9 | 151.2 | 186.3 | 182.4 | |
Shares outstanding (eoy) | m | 81.53 | 81.53 | 81.53 | 86.80 | 86.80 | |
Price / Sales ratio | x | 4.9 | 3.3 | 4.3 | 3.8 | 3.0 | |
Avg P/E ratio | x | 32.8 | 19.2 | 26.3 | 72.4 | -101.8 | |
P/CF ratio (eoy) | x | 23.7 | 15.0 | 19.2 | 31.2 | 48.8 | |
Price / Book Value ratio | x | 3.0 | 2.2 | 2.6 | 2.4 | 1.8 | |
Dividend payout | % | 7.4 | 5.8 | 6.1 | 15.8 | 0 | |
Avg Mkt Cap | Rs m | 35,951 | 29,739 | 38,458 | 43,854 | 31,485 | |
Total wages/salary | Rs m | 1,764 | 1,966 | 2,353 | 2,645 | 2,873 |
SHILPA MEDICARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,334 | 9,079 | 9,011 | 11,455 | 10,501 | |
Other income | Rs m | 156 | 222 | 401 | 209 | 314 | |
Total revenues | Rs m | 7,489 | 9,301 | 9,412 | 11,664 | 10,815 | |
Gross profit | Rs m | 1,659 | 2,142 | 2,308 | 2,023 | 845 | |
Depreciation | Rs m | 421 | 438 | 540 | 798 | 955 | |
Interest | Rs m | 37 | 46 | 219 | 412 | 587 | |
Profit before tax | Rs m | 1,357 | 1,881 | 1,951 | 1,023 | -383 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 262 | 335 | 488 | 417 | -74 | |
Profit after tax | Rs m | 1,095 | 1,546 | 1,462 | 606 | -309 | |
Gross profit margin | % | 22.6 | 23.6 | 25.6 | 17.7 | 8.0 | |
Effective tax rate | % | 19.3 | 17.8 | 25.0 | 40.8 | 19.2 | |
Net profit margin | % | 14.9 | 17.0 | 16.2 | 5.3 | -2.9 |
SHILPA MEDICARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 5,451 | 6,239 | 8,625 | 8,872 | 7,680 | |
Current liabilities | Rs m | 2,534 | 4,108 | 5,875 | 6,115 | 7,829 | |
Net working cap to sales | % | 39.8 | 23.5 | 30.5 | 24.1 | -1.4 | |
Current ratio | x | 2.2 | 1.5 | 1.5 | 1.5 | 1.0 | |
Inventory Days | Days | 39 | 20 | 32 | 45 | 38 | |
Debtors Days | Days | 1,014 | 992 | 946 | 1,231 | 1,127 | |
Net fixed assets | Rs m | 10,650 | 13,654 | 17,296 | 19,883 | 21,344 | |
Share capital | Rs m | 82 | 82 | 82 | 87 | 87 | |
"Free" reserves | Rs m | 11,894 | 13,212 | 14,705 | 18,135 | 17,746 | |
Net worth | Rs m | 11,976 | 13,294 | 14,787 | 18,222 | 17,833 | |
Long term debt | Rs m | 811 | 1,650 | 4,742 | 3,536 | 2,888 | |
Total assets | Rs m | 16,100 | 19,892 | 26,324 | 28,755 | 29,024 | |
Interest coverage | x | 37.9 | 42.3 | 9.9 | 3.5 | 0.3 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.3 | 0.4 | 0.4 | |
Return on assets | % | 7.0 | 8.0 | 6.4 | 3.5 | 1.0 | |
Return on equity | % | 9.1 | 11.6 | 9.9 | 3.3 | -1.7 | |
Return on capital | % | 10.9 | 12.9 | 11.1 | 6.6 | 1.0 | |
Exports to sales | % | 54.2 | 57.2 | 56.1 | 56.7 | 26.4 | |
Imports to sales | % | 22.3 | 20.9 | 24.8 | 19.0 | 4.7 | |
Exports (fob) | Rs m | 3,976 | 5,191 | 5,058 | 6,493 | 2,770 | |
Imports (cif) | Rs m | 1,633 | 1,900 | 2,231 | 2,176 | 494 | |
Fx inflow | Rs m | 3,987 | 5,206 | 5,078 | 6,514 | 2,841 | |
Fx outflow | Rs m | 1,768 | 2,138 | 3,322 | 2,814 | 1,399 | |
Net fx | Rs m | 2,219 | 3,069 | 1,756 | 3,700 | 1,443 |
SHILPA MEDICARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,468 | 1,244 | 469 | 1,051 | 2,262 | |
From Investments | Rs m | -1,962 | -2,895 | -4,043 | -2,855 | -2,785 | |
From Financial Activity | Rs m | 101 | 1,755 | 4,364 | 829 | 458 | |
Net Cashflow | Rs m | -395 | 102 | 790 | -975 | -65 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Omprakash Inani | COMP SEC: Ritu Tiwary | YEAR OF INC: 1987 | BSE CODE: 530549 | FV (Rs): 1 | DIV YIELD (%): - |
Read: SHILPA MEDICARE 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SHILPA MEDICARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.